Allergan will be doing just fine with Latisse™

Even at this incredibly slow time of the year for blog traffic, we hit about 250% of our average readership yesterday with search engines finding our post on Allergan's new eyelash enhancing cosmeceutical, Latisse.

Lots of folks wanting to know where to buy Latisse - Allergan stock anyone?

(Aside: Among my other search term hits yesterday was: "'junior faculty' hate my job." It hit an older post on whether junior faculty should invest time in writing review articles. I suggest that the reader start adding feeds to many of our commenters who with whom they may be able to commiserate.)

More like this

The tagline is from Elaine D'Farley at Self magazine talking about the FDA's then-pending approval of Allergan's Latisse™ for cosmetic growth of longer, thicker eyelashes treatment of hypotrichosis of the eyelashes. While not expected until early 2009, Jacob Goldstein at the WSJ Health Blog clued…
I am running out of eyelash puns having written at least six posts since the summer of 2007 on a class of anti-glaucoma drugs that have been harnessed for their cosmetic side effect: promotion of eyelash growth. Bimatoprost (Lumigan®) and latanoprost (Xalatan®) are members of the prostamide class…
The existence of the drug Latisse is clearly a harbinger of the end of modern civilization, in more ways than one, but it is also intensely fascinating and creepy. When I first heard of it, about a year ago, I really thought it was some sort of satirical article about the current status of big…
This whole "cosmeceutical" thing probably shouldn't be in "Medicine & Health" but we did call your attention to today's news item back on 27 July 2007: Drug maker Allergan announced at a stock analyst's meeting this afternoon that it is filing a New Drug Application (NDA) for a cosmetic form…

search hits always interest me.

for a while i got a lot of hits on a search term along the lines of "flunk out of grad school", hitting a post where i had smacked down on some unrealistic whining i heard from a younger student.